All of Us Research Program
Do you want to change the future of health? The Froedtert & MCW health network is part of the National Institutes of Health All of Us Research Program. It has a simple mission — speed up health research breakthroughs. To do this, All of Us is asking one million people to share their health information. Learn how you can help make a difference by joining the All of Us Research Program.
A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial of Efficacy and Safety of Riluzole in Acute Spinal Cord Injury (RISCIS)
The purpose of this trial is to evaluate the efficacy and safety of riluzole in the treatment of patients with acute SCI.
Investigator: Shekar N. Kurpad, MD, PhD
Status: Currently enrolling